Lumida
/LXEO
⌘K
Lexeo Therapeutics Inc

Lexeo Therapeutics Inc

LXEO
$4.25USD-2.52%-0.11 today

MARKET CAP

348.7M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$4
$11

AI Summary

Stalk
TrimMedium

LXEO remains in a clear Stage 4 decline with persistent lower highs and lower lows below its major moving averages, confirming medium-term bearish bias. An active Lower Highs & Lower Lows pattern indicates supply dominance, while a short-term rally into the 9/21 EMA zone has improved ST trend but offers no durable reversal. Execution is deferred: wait for a stronger rally toward the 50 DMA before trimming exposure. A decisive failure back below the 9/21 EMAs would reinvigorate bearish conviction.

  • Pipeline targets rare diseases; clinical updates due at Sep 2 investor conferences
  • 13F ownership above 4 indicates strong hedge fund interest and support
  • Negative earnings yield (-3.46%) and weak profitability signal poor returns
Full analysis →
Insider Trades49 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 1, 2026SellLXEOLouis Edward TamayoChief Financial Officer4,641$4.49$348.7M-61.33%+6.52%$20.8K-4.56%Trim
Jul 1, 2026SellLXEOJose Manuel OteroChief Operating Officer4,666$4.48$348.7M-61.33%+6.52%$20.9K-3.28%Trim
Jul 1, 2026SellLXEONarinder Pal BhallaChief Medical Officer22,306$4.42$348.7M-61.33%+6.52%$98.6K-21.35%Trim
Jul 1, 2026SellLXEORichard Nolan TownsendChief Executive Officer25,947$4.48$348.7M-61.33%+6.52%$116.2K-6.43%Trim
May 18, 2026SellLXEOJose Manuel OteroChief Operating Officer1,302$5.07$348.7M-61.33%+6.52%$6.6K-0.99%Trim
May 18, 2026SellLXEORichard Nolan TownsendChief Executive Officer3,342$5.06$348.7M-61.33%+6.52%$16.9K-0.98%Trim
Apr 6, 2026SellLXEORichard Nolan TownsendChief Executive Officer55,000$5.69$348.7M-61.33%+6.52%$313.1K-13.92%10b5-1Trim
Mar 13, 2026BuyLXEORichard Nolan TownsendChief Executive Officer2,623$2.64$348.7M-61.33%+6.52%$6.9K+0.67%Trim
Mar 13, 2026BuyLXEOJose Manuel OteroChief Operating Officer5,930$2.64$348.7M-61.33%+6.52%$15.7K+4.73%Trim
Feb 18, 2026SellLXEOJose Manuel OteroChief Operating Officer3,016$6.40$348.7M-61.33%+6.52%$19.3K-2.35%Trim
Feb 18, 2026SellLXEORichard Nolan TownsendChief Executive Officer10,173$6.38$348.7M-61.33%+6.52%$64.9K-2.53%Trim
Nov 18, 2025SellLXEOTai Sandi SeeChief Development Officer386$9.27$348.7M-61.33%+6.52%$3.6K-0.59%Trim
Nov 18, 2025SellLXEOJenny RobertsonChief Legal Officer549$9.27$348.7M-61.33%+6.52%$5.1K-0.80%Trim
Nov 18, 2025SellLXEOEric AdlerChief Medical Officer615$9.27$348.7M-61.33%+6.52%$5.7K-0.84%Trim
Nov 18, 2025SellLXEOJose Manuel OteroChief Operating Officer721$9.27$348.7M-61.33%+6.52%$6.7K-1.12%Trim
Nov 18, 2025SellLXEORichard Nolan TownsendChief Executive Officer1,127$9.27$348.7M-61.33%+6.52%$10.4K-0.47%Trim
Oct 17, 2025SellLXEOJose Manuel OteroChief Technical Officer2,115$8.94$348.7M-61.33%+6.52%$18.9K-1.62%Trim
Oct 17, 2025SellLXEOEric AdlerChief Medical Officer3,382$8.94$348.7M-61.33%+6.52%$30.2K-2.26%Trim
Oct 17, 2025SellLXEOJenny RobertsonChief Legal Officer3,526$8.94$348.7M-61.33%+6.52%$31.5K-2.49%Trim
Oct 17, 2025SellLXEOTai Sandi SeeChief Development Officer3,888$8.94$348.7M-61.33%+6.52%$34.8K-2.87%Trim
Oct 17, 2025SellLXEORichard Nolan TownsendChief Executive Officer13,133$8.94$348.7M-61.33%+6.52%$117.4K-2.64%Trim
Sep 12, 2025BuyLXEORichard Nolan TownsendChief Executive Officer2,193$2.64$348.7M-61.33%+6.52%$5.8K+1.00%Trim
Aug 18, 2025SellLXEOTai Sandi SeeChief Development Officer382$4.67$348.7M-61.33%+6.52%$1.8K-0.64%Trim
Aug 18, 2025SellLXEOJenny RobertsonChief Legal Officer542$4.67$348.7M-61.33%+6.52%$2.5K-0.86%Trim
Aug 18, 2025SellLXEOEric AdlerChief Medical Officer608$4.67$348.7M-61.33%+6.52%$2.8K-0.90%Trim
Aug 18, 2025SellLXEORichard Nolan TownsendChief Executive Officer1,115$4.67$348.7M-61.33%+6.52%$5.2K-0.50%Trim
Aug 18, 2025SellLXEOJose Manuel OteroChief Technical Officer721$9.27$348.7M-61.33%+6.52%$6.7K-1.12%Trim
Aug 18, 2025SellLXEORichard Nolan TownsendChief Executive Officer2,735$4.67$348.7M-61.33%+6.52%$12.8K-1.23%Trim
Aug 18, 2025SellLXEOJose Manuel OteroChief Technical Officer2,848$4.67$348.7M-61.33%+6.52%$13.3K-4.50%Trim
May 16, 2025SellLXEOTai Sandi SeeChief Development Officer367$2.77$348.7M-61.33%+6.52%$1.0K-0.62%Trim
May 16, 2025SellLXEOJenny RobertsonChief Legal Officer521$2.77$348.7M-61.33%+6.52%$1.4K-0.82%Trim
May 16, 2025SellLXEOEric AdlerChief Medical Officer585$2.77$348.7M-61.33%+6.52%$1.6K-0.86%Trim
May 16, 2025SellLXEORichard Nolan TownsendChief Executive Officer1,074$2.77$348.7M-61.33%+6.52%$3.0K-0.48%Trim
Mar 14, 2025BuyLXEORichard Nolan TownsendChief Executive Officer2,128$2.61$348.7M-61.33%+6.52%$5.6K+0.97%Trim
Mar 14, 2025BuyLXEOTai Sandi SeeChief Development Officer5,720$2.61$348.7M-61.33%+6.52%$14.9K+10.61%Trim
Mar 14, 2025BuyLXEOJenny RobertsonChief Legal Officer5,720$2.61$348.7M-61.33%+6.52%$14.9K+9.88%Trim
Mar 14, 2025BuyLXEOJose Manuel OteroChief Technical Officer5,720$2.61$348.7M-61.33%+6.52%$14.9K+9.95%Trim
Feb 19, 2025SellLXEOTai Sandi SeeChief Development Officer1,486$4.41$348.7M-61.33%+6.52%$6.6K-2.68%Trim
Feb 19, 2025SellLXEOJenny RobertsonChief Legal Officer2,101$4.41$348.7M-61.33%+6.52%$9.3K-3.50%Trim
Feb 19, 2025SellLXEOEric AdlerChief Medical Officer2,359$4.41$348.7M-61.33%+6.52%$10.4K-3.34%Trim
Feb 19, 2025SellLXEORichard Nolan TownsendChief Executive Officer4,326$4.41$348.7M-61.33%+6.52%$19.1K-1.93%Trim
Dec 10, 2024SellLXEORichard Nolan TownsendChief Executive Officer5,000$5.26$348.7M-61.33%+6.52%$26.3K+0.00%10b5-1Trim
Nov 11, 2024SellLXEORichard Nolan TownsendChief Executive Officer5,000$5.08$348.7M-61.33%+6.52%$25.4K+0.00%10b5-1Trim
Oct 10, 2024SellLXEORichard Nolan TownsendChief Executive Officer10,000$5.21$348.7M-61.33%+6.52%$52.1K+0.00%10b5-1Trim
Sep 10, 2024SellLXEORichard Nolan TownsendChief Executive Officer10,000$6.49$348.7M-61.33%+6.52%$64.9K+0.00%10b5-1Trim
Aug 12, 2024SellLXEORichard Nolan TownsendChief Executive Officer10,000$6.93$348.7M-61.33%+6.52%$69.3K+0.00%10b5-1Trim
Jul 10, 2024SellLXEORichard Nolan TownsendChief Executive Officer60,000$15.58$348.7M-61.33%+6.52%$935.0K-5.51%10b5-1Trim
Jun 10, 2024SellLXEORichard Nolan TownsendChief Executive Officer10,000$9.99$348.7M-61.33%+6.52%$99.9K+0.00%10b5-1Trim
May 13, 2024SellLXEORichard Nolan TownsendChief Executive Officer10,000$7.77$348.7M-61.33%+6.52%$77.7K+0.00%10b5-1Trim